These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10934733

  • 1. Evaluation of high molecular weight poly(oxyethylene) (Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules.
    Efentakis M, Vlachou M.
    Pharm Dev Technol; 2000; 5(3):339-46. PubMed ID: 10934733
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dielectric and thermodynamic properties of biodegradable poly(D,L-lactide-co-glycolide) and the effect on the micro-encapsulation and release of captopril.
    Schartel B, Volland C, Li YX, Wendorff JW, Kissel T.
    J Microencapsul; 1997; 14(4):475-88. PubMed ID: 9229347
    [Abstract] [Full Text] [Related]

  • 7. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE, Ganley JA, Bedford K, Eaves T.
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [Abstract] [Full Text] [Related]

  • 8. Fatty acid and water-soluble polymer-based controlled release drug delivery system.
    Desai D, Kothari S, Chen W, Wang J, Huang M, Sharma L.
    J Pharm Sci; 2011 May; 100(5):1900-12. PubMed ID: 21374622
    [Abstract] [Full Text] [Related]

  • 9. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 10. Formulation and pharmacodynamic evaluation of captopril sustained release microparticles.
    El-Kamel AH, Al-Shora DH, El-Sayed YM.
    J Microencapsul; 2006 Jun; 23(4):389-404. PubMed ID: 16854815
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC, Sumitra G M.
    J Control Release; 2002 Feb 19; 79(1-3):157-64. PubMed ID: 11853927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E, Yépez-Mulia L, Jesús Hernández-Abad V, Jung Cook H.
    Pharm Dev Technol; 2015 May 19; 20(3):306-13. PubMed ID: 24417644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.